Developing a biosimilar version of Roche's Lucentis treatment for wet AMD.
Industry: Health Care
First Day Return: -11.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/05/2014 |
Offer Price | $6.00 |
Price Range $8.00 - $8.00 | |
Offer Shares (mm) | 8.3 |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/23/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | San Diego, CA, United States |
Founded | 2009 |
Employees at IPO | 25 |
Website www.pfenex.com |